PT Kalbe Farma Tbk · IDX:KLBF
PT Kalbe Farma Tbk — Investor Presentation (February 2012)
10 slides from PT Kalbe Farma Tbk's investor presentation, February 2012
Slide 1: Analyst Briefing February 2012
2/16/2012 Analyst Briefing February 2012 Table of Contents MARKET OVERVIEW 3 BUSINESS OVERVIEW 2011 8 OUR STRATEGIES IN 2012 13 2 1
Slide 2: Low But Rising Healthcare Expenditure
2/16/2012 MARKET OVERVIEW 3 Low But Rising Healthcare Expenditure Healthcare Expenditure/GDP 2010 Total Healthcare Expenditure (%) Per capita (Rp Tn) 4.8% 4.1% Growth of 14.1% 247 3.8% 221 3.5% 3.3% 196 173 153 133 2.1% 116 101 86 Malaysia Thailand Philippines India Singapore Indonesia 2007 2008 200
Slide 3: Low Pharmaceuticals Spending Due To Low Penetration
2/16/2012 Low Pharmaceuticals Spending Due To Low Penetration Pharmaceuticals Spending Pharmaceuticals Spending per Capita 2010 (US Dollar) (Rp Tn) 63 119.6 Growth 12.6% 57 52 46 42 38 34 30 58.6 50.3 24 29.9 17.4 11.4 Singapore Thailand Malaysia Philippines Indonesia India 2007 2008 2009 2010 2011F
Slide 4: Nutritional Market Overview
2/16/2012 Nutritional Market Overview Indonesia Milk Product Wholesale Sales val. Breakdown Growth of Indonesian Powdered Milk Market By Volume (Kg ‘000) By Value (Rp Bn) 7 BUSINESS OVERVIEW 2011 8 4
Slide 5: Business Overview 2011
2/16/2012 BUSINESS OVERVIEW 2011 • Launched innovative new products • Expansion of Distribution & Logistics infrastructures Banjarmasin Jember Surakarta Aceh • Built new production facilities dedicated for oncology and unbranded generics pharmaceutical products New production facility for New produc
Slide 6: Indicative Results 2011
2/16/2012 INDICATIVE RESULTS 2011 Net Sales Gross Profit Operating Profit 2,000 17.9% +9.0%* 5,600 50.5% 50.8% 51.0% 17.8% 17.5% +6.7% 5,500 5,541 50.0% 1,950 17.6% +7.2% 1,948 17.4% 5,400 49.0% 1,900 +8.8% 17.2% 10,909 5,300 1,850 17.0% 10,227 48.0% 5,200 16.8% 1,800 16.6% 47.0% 5,100 5,166 1,791 1
Slide 7: Our Strategies in 2012
2/16/2012 OUR STRATEGIES IN 2012 13 STRATEGIES FOR 2012 1. Increase effectiveness of marketing and sales through branding management, with integrated marketing strategy and corporate branding 14 7
Slide 8: Strategies for 2012
2/16/2012 STRATEGIES FOR 2012 2. Strengthen business portfolio through innovation and new business model • Prescription Pharmaceuticals • Obtain new licensed products • Develop specialty products in Oncology • New generic production facility • Consumer Health • Launch innovative new products with na
Slide 9: Outlook 2012
2/16/2012 STRATEGIES FOR 2012 3. Expand and deepen market penetration in Indonesia and ASEAN ASEAN • Launch selected new products in key countries 17 OUTLOOK 2012 • New business mix with higher contribution from Distribution & Logistics Division • Higher marketing spending to gain market share Earni
Slide 10: Thank You
2/16/2012 Thank You For further information: PT Kalbe Farma Tbk. Jalan Let.Jend. Suprapto Kav. 4 Jakarta 10510, Indonesia Tel. : 62-21-42873888 Fax. : 62-21-42873678 Email : vidjongtius@kalbe.co.id jhandajani@kalbe.co.id investor.relations@kalbe.co.id Website : www.kalbe.co.id 19 10
PT Kalbe Farma — Investor Presentation (February 2012) on 6ix